Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
does anyone know by when FDA has to reply to gern's submission? I thought it was by Jan?
Is that air under the wings or the goose flying into the jet engine?
Hoping for news of more Inducement grants. LOL
3.3 mil sold after hours, bringing total day to appx 10 mil
I'll hold my decision until the FDA decision. All the data shows this drug works and anyone who doubts that can't read. i've held this long enough, a couple more months won't do much harm.
This board needs to resign …. It’s worse than the Biden administration and I didn’t think that was possible
The bear jerkoffs on yahoo are complete idiots but they are correct about this stock …. This is not a cancer cure the NDA was complete bullshit !
I hope this goes out of business…. It’s obvious now what a scam this is
>>On September 29, 2023, Geron Corporation (“Geron” or the “Company”) announced that its Marketing Authorization Application (“MAA”) for the use of imetelstat for the treatment of transfusion-dependent anemia in patients with lower risk myelodysplastic syndromes has been validated for review by the European Medicines Agency (“EMA”). The MAA was submitted in September 2023, and is now under regulatory review by the European Committee for Medicinal Products for Human Use (CHMP) under the centralized procedure, which applies to all 27 EU member states, Iceland, Norway and Liechtenstein. Review of the MAA is expected to be approximately 14 months.
Divine intervention is a better way to say it …it is so far away from any news at all and who knows
Need some real surprising good news.
No, it’d be like acknowledging that Trump is a turd
Saying something good about this stock is like saying something good about Biden …it would be a total joke .
Games brokers play. On level 2 same brokers with bids & ask size same, with a penny separation. gotta love capitalism, lol.
I guess GS doesn't think this Company is shit. Feel bad for those who listened and sold. This is only the beginning. Next is getting FDA approval and then launch. Statistics do not lie, unlike some.
Level 2 has resistance at $2.66 & $2.70. After that it's at $3.31.
Found out why.
Geron Raised to Buy From Neutral by Goldman Sachs
September 12, 2023
05:37 AM ET
Geron Price Target Announced at $4.00/Share by Goldman Sachs
September 12, 2023
05:37 AM ET
Did something come out? Pre-market up 12% on 208,000 shares
Wow !!!! Longs need to be absolutely pissed off about what is going on
This board is very quiet .. with good reason this is going nowhere .. what a disappointment this stock is !!
Wow if I were long stock holders I would call webbush and tell them to shut the eff up. It plummets every time they talk
To imagine, a close friend of the family, tried to persuade me to invest in GERN.
Suggested I get boatloads, as his friend, an alleged investment counselor, provided him the
info, pls was going to surpass $5.
At that time, it was trading in the $2 range; much like it is today.
Glad I decided against it.
TRUISM
Anyone out there have any insight into who'll be on the advisory committee? Thanks.
It almost feels like sabotage. I hope there's nobody from J&J on the committee. LOL.
https://www.thepharmaletter.com/article/geron-gets-regular-fda-review-for-imetelstat-disappointing-investors
Vote for Biden again you fucking moron …
...But look at the bright side, this delay may actually effectuate a buyout. ??
Thanks for the warning, numb nuts. I think we all figured that out on our own.
Don’t be a jerkoff … careful it doesn’t completely collapse and believe me there is a better chance of that
Careful of what?
10 months is a long time … be careful
Waiting around TEN months for word can do that. It's a shame given the FDA has been working with them all this time that they're taking their sweet time with this. I was hoping for three months. Not a good look for either party.
Today was a back breaker …. Bad sign when the only good news you have breaks you
This company is just too scary … too much risk
I'd like to believe the SEC or someone is watching whoever shorted and their possible connection to the FDA...I'd like to believe.
Yup, that was it.
>>Geron says the FDA didn't grant its request for a priority review of imetelstat for the treatment of transfusion-dependent anemia in patients with lower risk myelodysplastic syndromes and instead assigned a standard review and target action date of June 16, 2024. Geron says the agency also plans to hold an advisory committee meeting as part of its review. The FDA had previously granted fast-track designation to imetelstat, paving the way for Geron to seek priority review, which shortens the FDA review period. Geron says that pending an FDA green light, it expects a U.S. imetelstat launch by the end of June 2024. Geron up 2.7% premarket to $2.70.
I'm not sure I agree either that's why I said "may". Or it could just be selling into news or market maker scare tactics. Still over a billion dollar market cap so...
Beware of these NWBO evangelist super pumper soldiers. All you need to do is look at my track record of correct calls on various boards over the years. Just one honest handle unlike these pumping boiler room types. When the right question are asked by me and a few others, the pumper-humpers all go into full Borg mode.
he is a fudster...nothing but garbage out of his mouth...he is prevalent on nwbo...everyone gives him hell because he is full of bs...best not to reply...
10 months to review the NDA...that is BS...we. need a new govt
Sorry can’t agree with you … this is bad what should have been great news and the only news they have for a long time has turned out like this …. Cannot see any silver lining in this
Market may not like the Advisory Committee component of the news as it introduces an unknown. But I would've expected it for this therapy. We'll see.
Wow this is the mail in the coffin….. what a waste
If this is what "sell on the news" looks like we'll be back to $1 by approval. LOL. Come on Geron, do something different just once!
>>Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has assigned a standard review and a Prescription Drug User Fee Act (PDUFA) action date of June 16, 2024 for Geron's New Drug Application (NDA) for imetelstat for the treatment of transfusion-dependent anemia in patients with lower risk myelodysplastic syndromes (MDS). In addition, the FDA informed the Company that it is currently planning to hold an advisory committee meeting as part of the NDA review.
"We look forward to working with the FDA to complete the NDA review process on a timely basis," said John A. Scarlett, M.D., Geron's Chairman and Chief Executive Officer. "With the PDUFA date now set, we continue to expect an imetelstat launch in the United States by the end of the first half of 2024, subject to FDA approval."
Thanks I will … MM have too much power to manipulate I have always thought that
Followers
|
252
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7832
|
Created
|
03/25/03
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |